These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16420149)

  • 1. Corticotropin-releasing factor-1 receptors in the basolateral amygdala mediate stress-induced anorexia.
    Jochman KA; Newman SM; Kalin NH; Bakshi VP
    Behav Neurosci; 2005 Dec; 119(6):1448-58. PubMed ID: 16420149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF.
    Pelleymounter MA; Joppa M; Carmouche M; Cullen MJ; Brown B; Murphy B; Grigoriadis DE; Ling N; Foster AC
    J Pharmacol Exp Ther; 2000 Jun; 293(3):799-806. PubMed ID: 10869378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of corticotropin-releasing factor receptors from the basolateral or central amygdala increases the tonic immobility response in guinea pigs: an innate fear behavior.
    Donatti AF; Leite-Panissi CR
    Behav Brain Res; 2011 Nov; 225(1):23-30. PubMed ID: 21741994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat.
    Sajdyk TJ; Fitz SD; Shekhar A
    Stress; 2006 Mar; 9(1):21-8. PubMed ID: 16753930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic stress-induced alterations in amygdala responsiveness and behavior--modulation by trait anxiety and corticotropin-releasing factor systems.
    Sandi C; Cordero MI; Ugolini A; Varea E; Caberlotto L; Large CH
    Eur J Neurosci; 2008 Nov; 28(9):1836-48. PubMed ID: 18973598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA.
    Pollandt S; Liu J; Orozco-Cabal L; Grigoriadis DE; Vale WW; Gallagher JP; Shinnick-Gallagher P
    Eur J Neurosci; 2006 Sep; 24(6):1733-43. PubMed ID: 17004937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential dose effects of central CRF and effects of CRF astressin on pig behavior.
    Salak-Johnson JL; Anderson DL; McGlone JJ
    Physiol Behav; 2004 Oct; 83(1):143-50. PubMed ID: 15501501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of corticotropin-releasing factor type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats.
    Kamdi SP; Nakhate KT; Dandekar MP; Kokare DM; Subhedar NK
    Appetite; 2009 Dec; 53(3):354-62. PubMed ID: 19635511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.
    Bijlsma EY; van Leeuwen ML; Westphal KG; Olivier B; Groenink L
    Neuroscience; 2011 Jan; 173():82-92. PubMed ID: 21093544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of CRF/CRFR1 signaling in the basolateral nucleus of the amygdala contributes to chronic forced swim-induced depressive-like behaviors in rats.
    Chen L; Li S; Cai J; Wei TJ; Liu LY; Zhao HY; Liu BH; Jing HB; Jin ZR; Liu M; Wan Y; Xing GG
    Behav Brain Res; 2018 Feb; 338():134-142. PubMed ID: 29080675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential actions of corticotropin releasing factor on basolateral and central amygdaloid neurones, in vitro.
    Rainnie DG; Fernhout BJ; Shinnick-Gallagher P
    J Pharmacol Exp Ther; 1992 Nov; 263(2):846-58. PubMed ID: 1331417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain is a salient "stressor" that is mediated by corticotropin-releasing factor-1 receptors.
    Hummel M; Cummons T; Lu P; Mark L; Harrison JE; Kennedy JD; Whiteside GT
    Neuropharmacology; 2010 Sep; 59(3):160-6. PubMed ID: 20470804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice.
    Miguel TT; Nunes-de-Souza RL
    Horm Behav; 2011 Aug; 60(3):292-300. PubMed ID: 21723867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety.
    Shekhar A; Truitt W; Rainnie D; Sajdyk T
    Stress; 2005 Dec; 8(4):209-19. PubMed ID: 16423710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro- and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors.
    Ji G; Neugebauer V
    J Neurophysiol; 2008 Mar; 99(3):1201-12. PubMed ID: 18171711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine pre-exposure enhances CRF-induced expression of c-fos mRNA in the central nucleus of the amygdala: an effect that parallels the effects of cocaine pre-exposure on CRF-induced locomotor activity.
    Erb S; Funk D; Lê AD
    Neurosci Lett; 2005 Aug; 383(3):209-14. PubMed ID: 15955413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does amygdaloid corticotropin-releasing hormone (CRH) mediate anxiety-like behaviors? Dissociation of anxiogenic effects and CRH release.
    Merali Z; Khan S; Michaud DS; Shippy SA; Anisman H
    Eur J Neurosci; 2004 Jul; 20(1):229-39. PubMed ID: 15245495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential activation of CRF receptor subtypes removes stress-induced memory deficit and anxiety.
    Todorovic C; Radulovic J; Jahn O; Radulovic M; Sherrin T; Hippel C; Spiess J
    Eur J Neurosci; 2007 Jun; 25(11):3385-97. PubMed ID: 17553007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function.
    Martínez V; Rivier J; Wang L; Taché Y
    J Pharmacol Exp Ther; 1997 Feb; 280(2):754-60. PubMed ID: 9023288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin-releasing factor increases dihydropyridine- and neurotoxin-resistant calcium currents in neurons of the central amygdala.
    Yu B; Shinnick-Gallagher P
    J Pharmacol Exp Ther; 1998 Jan; 284(1):170-9. PubMed ID: 9435175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.